(Q33330920)

25 July 2017

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer (English)

1 reference

25 July 2017

1 reference

1 reference

Laohavinij S

1

1 reference

25 July 2017

Maoleekoonpairoj S

2

1 reference

25 July 2017

Cheirsilpa A

3

1 reference

25 July 2017

Maneechavakajorn J

4

1 reference

25 July 2017

Sirachainant E

5

1 reference

25 July 2017

Arpornvivat W

6

1 reference

25 July 2017

Jaisathaporn K

7

1 reference

25 July 2017

Ratanatharathorn V

8

1 reference

25 July 2017

1 December 1999

1 reference

25 July 2017

1 reference

25 July 2017

26

1 reference

25 July 2017

3

1 reference

25 July 2017

175-185

1 reference

The new International Staging System for Lung Cancer.

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Extensive and saturable accumulation of paclitaxel by the human platelet

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900089-6

7 January 2021

10.1016/S0169-5002(99)00089-6

Identifiers

DOI

1 reference

25 July 2017

1 reference